Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Albireo Pharma (ALBO) Prices 4M Share Common Offering at $40/Sh
-
Albireo Prices Public Offering of 4,000,000 Shares of Common Stock
-
Albireo Pharma (ALBO) Announces Proposed Public Offering of 3M Shares of Common Stock
-
Albireo Announces Proposed Public Offering of 3,000,000 Shares of Common Stock
-
Albireo to Present at Cowen and Company 40th Annual Health Care Conference
-
Albireo Reports First Quarter 2019 Financial Results
-
Albireo to Present at Cowen and Company 39th Annual Health Care Conference
-
Albireo Provides First Quarter 2018 Business Update
-
Albireo to Present at 38th Annual Cowen and Company Health Care Conference
-
Albireo Announces Closing of $74.8 Million Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares
-
Albireo Pharma (ALBO) Prices 1.97M Common Stock Offering at $33/Share
-
Albireo Prices $65.0 Million Public Offering of Common Stock
-
Albireo Pharma (ALBO) to Offer Common Stock
-
Albireo Announces Proposed Public Offering of Common Stock
-
Cowen Starts Albireo Pharma (ALBO) at Outperform
-
Albireo Announces Closing of $51.9 Million Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares
-
Albireo Pharma (ALBO) Prices 2.2M Common Stock Offering at $20.50/Share
-
Albireo Prices $45.1 Million Public Offering of Common Stock
-
Albireo Pharma (ALBO) Commences Offering of Common Stock
-
Albireo Announces Proposed Public Offering of Common Stock
-
Albireo to Present at 37th Annual Cowen and Company Health Care Conference

